Currently, AIM ImmunoTech Inc [AIM] is trading at $0.27, down -3.57%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The AIM shares have gain 6.85% over the last week, with a monthly amount drifted -24.98%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
This stock has fluctuated between a low of $0.21 and a high of $0.62 over the last 52 weeks. AIM ImmunoTech Inc [AMEX: AIM] shares were valued at $0.27 at the most recent close of the market.
Analyzing the AIM fundamentals
Trailing Twelve Months sales for AIM ImmunoTech Inc [AMEX:AIM] were 0.20M which represents 19.05% growth. Gross Profit Margin for this corporation currently stands at -0.17% with Operating Profit Margin at -155.39%, Pretax Profit Margin comes in at -139.53%, and Net Profit Margin reading is -139.53%. To continue investigating profitability, this company’s Return on Assets is posted at -1.78, Equity is -2.56 and Total Capital is -4.54. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.47.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.2557 points at the first support level, and at 0.2415 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.2835, and for the 2nd resistance point, it is at 0.2971.
Ratios To Look Out For
To put it in perspective, the Current Ratio for AIM ImmunoTech Inc [AMEX:AIM] is 1.17. Also, the Quick Ratio is 1.17, while the Cash Ratio stands at 0.4. Considering the valuation of this stock, the price to sales ratio is 77.14, the price to book ratio is 2.53.
Transactions by insiders
Recent insider trading involved Equels Thomas K, CEO & President, that happened on Sep 16 ’24 when 5000.0 shares were purchased. CEO & President, Equels Thomas K completed a deal on Sep 13 ’24 to buy 20000.0 shares. Meanwhile, CEO & President Equels Thomas K bought 61729.0 shares on May 06 ’24.
